论文部分内容阅读
目的探讨放化疗联合脑转移瘤放疗治疗非小细胞肺癌脑转移的临床疗效。方法选取43例非小细胞肺癌脑转移的患者作为研究对象,给予患者放化疗联合脑转移瘤放疗治疗,观察患者的生存情况及临床治疗效果。结果 43例患者经过相应的临床治疗后,1年存活率为69.8%(30/43),2年存活率为46.5%(20/43),3年存活率为25.6%(11/43)。结论采用放化疗联合脑转移瘤放疗治疗非小细胞肺癌脑转移的临床疗效显著,值得临床推广使用。
Objective To investigate the clinical effects of radiotherapy and chemotherapy combined with brain metastases on brain metastases of non-small cell lung cancer. Methods Forty-three patients with brain metastases from non-small cell lung cancer were enrolled in this study. Patients were treated with radiotherapy and chemotherapy combined with radiotherapy for brain metastases, and their survival and clinical effects were observed. Results After the corresponding clinical treatment, the survival rate of one year was 69.8% (30/43). The 2 - year survival rate was 46.5% (20/43) and the 3 - year survival rate was 25.6% (11/43). Conclusions Radiotherapy with radiotherapy and chemotherapy combined with brain metastases in the treatment of brain metastases of non-small cell lung cancer has a significant clinical effect and is worthy of clinical promotion.